Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Allergy, Drug

lamivudine has been researched along with Allergy, Drug in 23 studies

Research

Studies (23)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's12 (52.17)29.6817
2010's10 (43.48)24.3611
2020's1 (4.35)2.80

Authors

AuthorsStudies
Ali, SM; Karoney, MJ; Kigen, G; Koech, MK1
Bayonne Kombo, ES; Gathse, A1
Kitaichi, T; Kitazono, Y; Kurita, T; Miura, T; Nagao, T1
Domingo, P; Rivero, A1
Cárden-Santana, MA; Carrillo-Díaz, T; Castillo-Sainz, R; Suárez-Lorenzo, I1
Andany, N; Gold, WL1
Emerson, CR; Todd, S1
Itoh, A; Naoki, H; Sugiura, K; Sugiura, M; Takashi, T1
Bánhegyi, D; Bannister, WP; Chiesi, A; Friis-Møller, N; Gargalianos, P; Kirk, O; Lundgren, JD; Mocroft, A; van Lunzen, J; Viard, JP1
Bravo, I; Carosi, G; Clotet, B; del Arco, A; Echeverría, P; Gálvez, J; Gómez, JL; López, JC; López-Blazquez, R; Mariño, A; Moreno, A; Negredo, E; Ocampo, A; Pedrol, E; Pérez-Alvarez, N; Portilla, J; Prieto, A; Rubio, R; Viladés, C1
Baudewig, M; Becker, W; Blankenburg, M; Bogner, JR; Gorriahn, D; Jaeger, H; Mueller, MC; Stoll, M; Walli, R; Welte, R; Wolf, E1
Ahmed, YI; Chasela, CS; Chigwenembe, M; Ellington, SR; Fiscus, SA; Hoffman, IF; Hosseinipour, MC; Hudgens, MG; Jamieson, DJ; Kacheche, Z; Kamwendo, DD; Kayira, D; Kazembe, P; Knight, RJ; Kourtis, AP; Martinson, F; Mofolo, IA; Sichali, DS; Soko, A; Tegha, G; van der Horst, CM; Wiener, JB1
Loulergue, P; Mir, O1
Beauvais, L; Clumeck, N; Fenske, S; Gazzard, B; Katlama, C; Lafeuillade, A; Lazzarin, A; Mallolas, J; Mamet, JP1
Korman, TM; Tapley, N; Woolley, I1
Angel-Moreno-Maroto, A; Hernández-Cabrera, M; Pérez-Arellano, JL; Suárez-Castellano, L1
Brothers, CH; Castillo, SA; Hernandez, JE1
Galli, M; Gervasoni, C; Grinelli, E; Ortu, M; Rusconi, S; Vigano, O1
Boom, WH; Charlebois, ED; Havlir, DV; Kayanja, HK; Lin, R; Mayanja-Kizza, H; Mugerwa, RD; Srikantiah, P; Walusimbi, MN; Whalen, CC1
McLean, K; Winston, A1

Reviews

1 review(s) available for lamivudine and Allergy, Drug

ArticleYear
[Safety profile of dolutegravir].
    Enfermedades infecciosas y microbiologia clinica, 2015, Volume: 33 Suppl 1

    Topics: Bone Remodeling; Clinical Trials as Topic; Creatinine; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Therapy, Combination; Gastrointestinal Diseases; Headache; Hepatitis, Viral, Human; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV Integrase Inhibitors; Humans; Immune Reconstitution Inflammatory Syndrome; Kidney Tubules; Lamivudine; Lipid Metabolism; Mood Disorders; Organic Cation Transport Proteins; Organic Cation Transporter 2; Oxazines; Piperazines; Pyridones; Respiration Disorders; Sleep Initiation and Maintenance Disorders

2015

Trials

3 trial(s) available for lamivudine and Allergy, Drug

ArticleYear
Similar antiviral efficacy and tolerability between efavirenz and lopinavir/ritonavir, administered with abacavir/lamivudine (Kivexa), in antiretroviral-naïve patients: a 48-week, multicentre, randomized study (Lake Study).
    Antiviral research, 2010, Volume: 85, Issue:2

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; Humans; Lamivudine; Lopinavir; Male; Middle Aged; Pyrimidinones; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load; Withholding Treatment

2010
Maternal or infant antiretroviral drugs to reduce HIV-1 transmission.
    The New England journal of medicine, 2010, Jun-17, Volume: 362, Issue:24

    Topics: Adult; Anti-Retroviral Agents; Breast Feeding; CD4 Lymphocyte Count; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV Seronegativity; HIV-1; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Kaplan-Meier Estimate; Lamivudine; Male; Neutropenia; Nevirapine; Pregnancy; Risk Factors; Stevens-Johnson Syndrome; Young Adult; Zidovudine

2010
TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.
    HIV medicine, 2003, Volume: 4, Issue:2

    Topics: Adult; Aged; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chi-Square Distribution; Cholesterol; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; HIV-1; Humans; Lamivudine; Male; Middle Aged; Protease Inhibitors; RNA, Viral; Statistics, Nonparametric; Triglycerides; Viral Load; Zidovudine

2003

Other Studies

19 other study(ies) available for lamivudine and Allergy, Drug

ArticleYear
Severe abacavir hypersensitivity reaction in a patient with human immunodeficiency virus infection: a case report.
    Journal of medical case reports, 2022, Nov-08, Volume: 16, Issue:1

    Topics: Adult; Anti-HIV Agents; Anti-Retroviral Agents; Child; Dideoxynucleosides; Drug Hypersensitivity; Female; HIV Infections; Humans; Kenya; Lamivudine; Vomiting

2022
[Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Medecine et maladies infectieuses, 2013, Volume: 43, Issue:3

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asthenia; Benzoxazines; Cyclopropanes; Deoxycytidine; Dideoxynucleosides; Drug Eruptions; Drug Hypersensitivity; Drug Substitution; Emtricitabine; Female; Fever; HIV Infections; Humans; Lamivudine; Nevirapine; Organophosphonates; Reverse Transcriptase Inhibitors; Syndrome; Tenofovir

2013
Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan.
    Pharmacoepidemiology and drug safety, 2014, Volume: 23, Issue:4

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; HIV Infections; Humans; Incidence; Japan; Lamivudine; Myocardial Ischemia; Product Surveillance, Postmarketing

2014
Severe reaction to emtricitabine and lamiduvine: evidence of cross-reactivity.
    Contact dermatitis, 2016, Volume: 74, Issue:4

    Topics: Anti-HIV Agents; Cross Reactions; Drug Eruptions; Drug Hypersensitivity; Emtricitabine; Female; HIV Infections; Humans; Lamivudine; Middle Aged; Patch Tests; Stevens-Johnson Syndrome

2016
Single-tablet antiretroviral treatment (once daily).
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2016, Sep-20, Volume: 188, Issue:13

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Drug Interactions; Drug Resistance, Viral; Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine, Rilpivirine, Tenofovir Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; Humans; Lamivudine; Mental Disorders; Oxazines; Piperazines; Pyridones; Viral Load

2016
A severe hypersensitivity reaction to abacavir following re-challenge.
    International journal of STD & AIDS, 2017, Volume: 28, Issue:3

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Hypersensitivity; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Heterocyclic Compounds, 3-Ring; HIV Infections; HIV-1; HLA-B Antigens; Humans; Lamivudine; Oxazines; Piperazines; Pyridones

2017
Immediate allergy, drug-induced eruption, by entecavir.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:4

    Topics: Adult; Antiviral Agents; Drug Eruptions; Drug Hypersensitivity; Guanine; Hepatitis B; Humans; Lamivudine; Male

2009
Incidence of abacavir hypersensitivity reactions in euroSIDA.
    Antiviral therapy, 2008, Volume: 13, Issue:5

    Topics: Adult; Anti-HIV Agents; Cohort Studies; Dideoxynucleosides; Drug Administration Schedule; Drug Hypersensitivity; Drug Therapy, Combination; Europe; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Middle Aged; Poisson Distribution; Reverse Transcriptase Inhibitors; Treatment Outcome; Zidovudine

2008
Cost impact of prospective HLA-B*5701-screening prior to abacavir/lamivudine fixed dose combination use in Germany.
    European journal of medical research, 2010, Apr-08, Volume: 15, Issue:4

    Topics: Anti-HIV Agents; Costs and Cost Analysis; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Germany; HLA-B Antigens; Hospitalization; Humans; Lamivudine; Mass Screening; Retrospective Studies; Reverse Transcriptase Inhibitors

2010
Letter to the editor: Hypersensitivity to lamivudine and emtricitabine.
    Current HIV research, 2012, Volume: 10, Issue:7

    Topics: Aged; Anti-HIV Agents; Deoxycytidine; Dose-Response Relationship, Drug; Drug Hypersensitivity; Drug Therapy, Combination; Emtricitabine; Female; HIV Seropositivity; HIV-1; Humans; Lamivudine

2012
Sequential cutaneous drug reactions to protease inhibitors in the context of occupational post-exposure prophylaxis.
    AIDS (London, England), 2003, Jul-25, Volume: 17, Issue:11

    Topics: Adult; Drug Hypersensitivity; Female; Guideline Adherence; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Needlestick Injuries; Occupational Diseases; Occupational Exposure; Zidovudine

2003
Two-once-daily fixed-dose NRTI combinations for HIV.
    The Medical letter on drugs and therapeutics, 2005, Feb-28, Volume: 47, Issue:1203

    Topics: Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Combinations; Drug Hypersensitivity; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV Infections; Humans; Lamivudine; Organophosphorus Compounds

2005
Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.
    The Journal of infection, 2006, Volume: 52, Issue:2

    Topics: Acute Kidney Injury; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Ghana; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Mycobacterium tuberculosis; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Tuberculosis

2006
Long-term safety and tolerability of the lamivudine/abacavir combination as components of highly active antiretroviral therapy.
    Drug safety, 2006, Volume: 29, Issue:9

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Controlled Clinical Trials as Topic; Cyclopropanes; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Incidence; Lamivudine; Male; Oxazines; Prospective Studies; Time Factors; Treatment Outcome; Zidovudine

2006
Abacavir hypersensitivity reaction after switching from the twice-daily to the once-daily formulation.
    AIDS patient care and STDs, 2007, Volume: 21, Issue:1

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Dideoxynucleosides; Drug Administration Schedule; Drug Hypersensitivity; HIV Infections; Humans; Lamivudine; Male; Oxazines; RNA, Viral

2007
Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda.
    AIDS (London, England), 2007, Sep-12, Volume: 21, Issue:14

    Topics: Adult; Antitubercular Agents; CD4 Lymphocyte Count; Dideoxynucleosides; Drug Hypersensitivity; Drug Therapy, Combination; Female; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Neutropenia; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Tuberculosis, Pulmonary; Zidovudine

2007
Abacavir: new preparation. Risks limit the value.
    Prescrire international, 2000, Volume: 9, Issue:47

    Topics: Adult; Antiviral Agents; Child; Clinical Trials as Topic; Cost-Benefit Analysis; Dideoxynucleosides; Drug Hypersensitivity; Drug Interactions; Drug Therapy, Combination; France; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Risk Assessment; Treatment Outcome; Zidovudine

2000
Approval comes with warning.
    AIDS patient care and STDs, 2001, Volume: 15, Issue:2

    Topics: Anti-HIV Agents; Dideoxynucleosides; Drug Approval; Drug Combinations; Drug Hypersensitivity; Humans; Lamivudine; United States; United States Food and Drug Administration; Zidovudine

2001
Recurrent hypersensitivity to Combivir.
    International journal of STD & AIDS, 2002, Volume: 13, Issue:3

    Topics: Adult; Anti-HIV Agents; Drug Combinations; Drug Hypersensitivity; Female; HIV Infections; HIV-1; Humans; Lamivudine; Recurrence; Zidovudine

2002